Live tape
Top 8, mentions 7d8,148NKE2,137 mentions▲ +0.03GOOGL1,612 mentions▲ +0.04NVDA904 mentions▲ +0.09META816 mentions▲ +0.05QQQ726 mentions▲ +0.08TSLA708 mentions▲ +0.07SPCX687 mentions▲ +0.09MSFT558 mentions▲ +0.05

Equity · Healthcare

RXRX

NASDAQ

Recursion Pharmaceuticals, Inc.

$4.13 +1.23% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 2, 2026

Reddit mentioned RXRX 10 times in the 30 days to 5 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 80% read bullish, 10% bearish and 10% neither. Reddit data updated 5 October 2026.

Price · Chart
63 sessions
$4.5 $2.5 7 Jul 2 Oct

The line runs $3.83 on 7 July through $4.13 on 2 October, on a scale from $2.5 to $4.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 7 Jul – 2 Oct 2026
Market cap $2.2B
52-week range $2.81 – $7
Avg volume 1.1M
Mentions · 30d 10
Net sentiment +0.13

as of Oct 2, 2026

RXRX · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
10 mentions

Day4 Oct 2026

MENTIONS20–3 / day
PRICE$4.13 · closedMARKET CLOSED · held
RXRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day0123usd$3.0$3.5$4.0$4.56 Sep13 Sep21 Sep28 Sep5 Oct
RXRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.6 Sep21 Sep5 Oct
The Distributed Sentinel 05 Oct 2026

RXRX drew 10 Reddit mentions over the 30 days to 5 October 2026

This chart in words

The chart plots daily Reddit mentions of RXRX over the 30 days to 5 October 2026: 10 in total, busiest on 21 September with 2, and 2 on the last day counted. The line is the daily close over the same window: $3.44 on 8 September, $4.13 on 2 October. Of those days, 19 were trading sessions and the other 11 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 2 of them no session took place, and this window holds no earlier close to carry forward; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Crowd sentiment on RXRX · 30d

n = 10 scored · Method
RXRX

80% bullish

Overall market sentiment

55% bullish

RXRX reads 25 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where RXRX is discussed

(30d)
r/wallstreetbets 90% 9 +0.13
r/investing 10% 1 +0.11

RXRX insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Sep 2026
Open-market buys 0
Open-market sells 4
Net sold $435K
Non-trade filings 6
Date Insider Type Shares Value
08 Sep 2026 Khan Najat CEO and President Sell 22,408 $79K
01 Sep 2026 Borgeson Blake Director Sell 30,000 $100K
04 Aug 2026 Borgeson Blake Director Sell 30,000 $98K
07 Jul 2026 Borgeson Blake Director Sell 40,000 $159K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2026 Dar Zavain Director Award 4,607
01 Oct 2026 Li Dean Y Director Award 3,378
15 Sep 2026 Taylor Ben R Chief Financial Officer Tax withheld 5,396 $18K
17 Aug 2026 Hallett David Chief Scientific Officer Tax withheld 26,657 $84K
17 Aug 2026 Khan Najat CEO and President Tax withheld 80,498 $254K
17 Aug 2026 Taylor Ben R Chief Financial Officer Tax withheld 25,018 $79K

RXRX reported financials

SEC EDGAR XBRL SEC EDGAR

RXRX reported revenue of $74.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$644.8M.

Figure Reported Period
Revenue $74.7M 31 Dec 2025 fiscal year
Net income −$644.8M 31 Dec 2025 fiscal year
Diluted EPS −$1.44 31 Dec 2025 fiscal year
Total assets $1.2B 30 Jun 2026 at period end
Total equity $915.0M 30 Jun 2026 at period end

RXRX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.25 $8M
31 Mar 2026 Q1 2026 −$0.22 $6M
31 Dec 2025 FY 2025 −$1.44 $75M
30 Sep 2025 Q3 2025 −$0.36 $5M
30 Jun 2025 Q2 2025 −$0.41 $19M
31 Mar 2025 Q1 2025 −$0.50 $15M
31 Dec 2024 FY 2024 −$1.69 $59M
30 Sep 2024 Q3 2024 −$0.34 $26M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

RXRX institutional holders

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a RXRX position for the quarter ended 30 Jun 2026 — a combined $194.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) +2.8% shares 41,337,632 $151.7M
Marshall Wace Added +63.9% shares 4,714,577 $17.3M
Two Sigma Investments Held (±25%) −17.5% shares 3,353,658 $12.3M
Millennium Management Trimmed −29.8% shares 1,834,762 $6.7M
Man Group Trimmed −36.2% shares 765,786 $2.8M
AQR Capital Management Added +72.7% shares 422,087 $1.5M
Balyasny Asset Management Added +111.7% shares 353,661 $1.3M
Citadel Advisors Trimmed −79.4% shares 128,478 $472K
D. E. Shaw & Co. Held (±25%) −17.6% shares 37,914 $139K
Bridgewater Associates New position 37,667 $138K

RXRX fails-to-deliver

SEC CNS data SEC

On 14 Sep 2026, 497,478 shares of RXRX failed to deliver (about $1.6M).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 497,478 $1.6M 0.093%
10 Sep 2026 400,138 $1.3M 0.075%
09 Sep 2026 72,869 $251K 0.014%
08 Sep 2026 1,917 $7K <0.001%
04 Sep 2026 73 $251 <0.001%
03 Sep 2026 247,538 $837K 0.046%
01 Sep 2026 189,092 $643K 0.035%
31 Aug 2026 345,423 $1.2M 0.065%
28 Aug 2026 4,021 $14K 0.001%
26 Aug 2026 302,205 $1.1M 0.056%
25 Aug 2026 124,054 $403K 0.023%
24 Aug 2026 135,512 $474K 0.025%

RXRX — frequently asked questions

From live data

How often is RXRX mentioned on Reddit?

RXRX was mentioned 5 times in the last 7 days across the finance subreddits we track, and 10 times over the trailing 30 days.

Is Reddit bullish or bearish on RXRX?

Across 10 classified RXRX mentions in the last 30 days, 80% read bullish, 10% bearish and 10% neutral. Crowd sentiment is a social signal, not investment advice.

When did RXRX last report earnings?

Recursion Pharmaceuticals (RXRX) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are RXRX insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 4 sells by RXRX insiders on the open market. A further 6 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is RXRX listed on?

Recursion Pharmaceuticals trades on NASDAQ under the ticker RXRX.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARValuation computed from SEC EDGAR filings